On or around 01/03/2020 (Date of last review)
Filing Date: January 03, 2020
According to the Complaint, Synthorx is a clinical-stage biotechnology company focused on prolonging and improving the lives of people with cancer and autoimmune disorders.
This action stems from a proposed transaction announced on December 9, 2019, pursuant to which Synthorx will be acquired by Sanofi.
On December 7, 2019, Synthorx’s Board of Directors caused Synthorx to enter into an agreement and plan of merger with Sanofi.
On December 23, 2019, Defendants filed a Solicitation/Recommendation Statement with the United States Securities and Exchange Commission in connection with the Proposed Transaction. The Complaint alleges that the Solicitation Statement omits material information with respect to the Proposed Transaction, which renders the Solicitation Statement false and misleading.
Company & Securities Information
Defendant: Synthorx, Inc.
Industry: Biotechnology & Drugs
Headquarters: United States
Ticker Symbol: THOR
Company Market: NASDAQ
Market Status: Public (Listed)
About the Company & Securities Data
"Company" information provides the industry and sector classification and headquarters state for the primary company-defendant in the litigation. In general, "Securities" information provides the ticker symbol, market, and market status for the underlying securities at issue in the litigation.
In most cases, the primary company-defendant actually issued the securities that are the subject of the litigation, and the securities information and company information relate to the same entity. In a small subset of cases, however, the primary company-defendant is not the issuer (for example, cases against third party brokers/dealers), and the securities information and company information do not relate to the same entity.
First Identified Complaint
Michael Kent, et al. v. Synthorx, Inc., et al.
COURT: D. Delaware
DOCKET #: 20-CV-00010
JUDGE: Hon. Colm F. Connolly
DATE FILED: 01/03/2020
CLASS PERIOD START: 12/09/2019
CLASS PERIOD END: 01/03/2020
PLAINTIFF FIRMS NAMED IN COMPLAINT:
Rigrodsky & Long, P.A. (Wilmington)
RM Law, P.C. (Berwyn)
First Identified Complaint (FIC) Filings:
Complaint for Violation of the Securities Exchange Act of 1934
U.S. District Court Civil Docket
—Reference Complaint Complaint Related Data is not available
Related District Court Filings
—Related District Court Filings Data is not available